Market Tracker

01/23 7:30am ET

Alkermes Plc (NASDAQ:ALKS)

55.98
Delayed Data
As of Jan 20
 -0.10 / -0.18%
Today’s Change
27.14
Today|||52-Week Range
61.56
+0.72%
Year-to-Date
BioCorRx Receives New Funding for Opioid Drug
Jan 22 / GuruFocus News - Paid Partner Content
 

Today’s Trading

Previous close56.08
Today’s open56.06
Day’s range55.14 - 56.32
Volume756,023
Average volume (3 months)1,083,549
Market cap$8.5B
Dividend yield--
Data as of 4:00pm ET, 01/20/2017

Growth & Valuation

Earnings growth (last year)-623.81%
Earnings growth (this year)+34.06%
Earnings growth (next 5 years)+57.70%
Revenue growth (last year)+1.54%
P/E ratioNM
Price/Sales18.85
Price/Book6.42

Competitors

 Today’s
change
Today’s
% change
SGENSeattle Genetics Inc-0.48-0.81%
TSROTESARO Inc-2.91-1.94%
RDYDr.Reddy's Laborator...+0.30+0.69%
JAZZJazz Pharmaceuticals...-0.54-0.43%
Data as of 4:02pm ET, 01/20/2017

Financials

Next reporting dateMarch 2, 2017
EPS forecast (this quarter)$0.03
Annual revenue (last year)$628.3M
Annual profit (last year)-$227.2M
Net profit margin-36.15%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Richard F. Pops
President
Shane M. Cooke
Corporate headquarters
Dublin, Dublin

Forecasts